Individualizing cardiac care, the field of Cardiac Personalized Medicine is at the forefront of transforming cardiovascular treatment paradigms. This innovative approach tailors medical interventions for heart health based on an individual's distinct genetic composition, lifestyle, and specific cardiac conditions. By embracing cutting-edge technologies, including genetics, biomarkers, and diagnostics, Cardiac Personalized Medicine aims to redefine how we approach prevention, diagnosis, and treatment of cardiovascular diseases. The personalized aspect extends beyond genetics, considering lifestyle factors and patient-specific cardiac nuances. The potential impact of Cardiac Personalized Medicine is profound, as it strives to not only enhance treatment precision but also to create a more patient-centered cardiovascular healthcare landscape. As advancements in research and technology persist, the evolution of personalized medicine promises to be a key driver in optimizing cardiac care outcomes.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation